AA
SLDB icon

ALPS Advisors’s Solid Biosciences SLDB Stock Holding History

ALPS Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$998K Buy
+99,916
New +$758K ﹤0.01% 702

Other funds holding SLDB

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

ALPS Advisors's SLDB Position: Q2 2026 in Review

ALPS Advisors opened a new position in Solid Biosciences (SLDB) in Q2 2026: 99,916 shares worth $998K. The stake represents ﹤0.01% of the portfolio and ranks #702 among its holdings.

19 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • ALPS Advisors held 99,916 shares of Solid Biosciences worth $998K as of Q2 2026.
  • Solid Biosciences was a new ALPS Advisors position in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #702 holding.
  • 19 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.